The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvacta Group Share News (AVCT)

Share Price Information for Avacta Group (AVCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 45.50
Bid: 45.00
Ask: 46.00
Change: -1.00 (-2.15%)
Spread: 1.00 (2.222%)
Open: 46.50
High: 45.50
Low: 45.00
Prev. Close: 46.50
AVCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

SUMMARY: London listings with exposure to Silicon Valley Bank

Mon, 13th Mar 2023 12:18

(Alliance News) - The following is a round-up of updates on exposure to Silicon Valley Bank by London-listed companies, issued on Monday and not separately reported by Alliance News:

----------

FTSE 250

----------

Syncona Ltd - London-based investor in healthcare companies - Says it has cash and cash equivalents with SVB UK Ltd equating less than 0.4% of its capital base of GBP653.8 million, and 0.2% of its net asset value. Portfolio companies have "range of banking relationships" including SVB and SVB UK, and estimates its indirect exposure across portfolio is around 6% of NAV, "with all but a de minimus amount with SVBUK". Working closely with portfolio companies to support ongoing operations, and engagement with SVBUK and other parties to recovery deposits. Has strong capital base to support portfolio companies if required, awaits guidance from Bank of England over progress and timeline to potentially recover deposits.

----------

IP Group PLC - Oxford, England-based intellectual property commercialisation company - Confirms no direct deposits, credit facilities or other relationships with SVB or SVB UK. Boasts strong balance sheet, with GBP241.5 million in gross cash and deposits as at December 31, and total potential liquidity of over GBP500 million. Working closely with "small number" of portfolio companies that may require short-term liquidity. "Our strong financial position means we are well placed to support our portfolio," firm says.

----------

Auction Technology Group PLC - London-based online auction operator - Says SVB is involved in its senior facilities arrangement with syndicate of six banks. The arrangement consists of a fully-drawn USD150.3 million senior term loan, and a USD49.0 million multi-currency revolving credit facility, which is drawn down by USD24.3 million. SVB represents one sixth of its respective drawn and undrawn facilities. Says liquidity position strong, benefitting from operational cash generation and access to liquidity from other five banks in syndicate. As at Thursday, has USD10.0 million cash at bank, with 5% held on deposit at SVB. "This deposit is held across the group's different US entities. The group uses JP Morgan Chase and HSBC for its main clearing and operational uses," firm says. Expects "no material impact" to current or future liquidity from SVB situation.

----------

Moonpig Group PLC - online greeting card and gifting company - Says SVB is one of ten lenders in banking syndicate which provide its senior debt facilities. Has "significant" liquidity headroom, including utilised and available facilities of GBP242 million, which are committed until December 8 2025. "This excludes the GBP13 million undrawn portion of SVB UK's commitment," firm says. Confirms no cash on deposit with SVB UK and no bank account held with them.

----------

Apax Global Alpha Ltd - Guernsey-based closed-ended investment company - Receives update from Apax Partners, which advises certain private equity funds in which it is a limited partner. Says review is ongoing but exposure to SVB "appears to be limited". Review has not identified any portfolio company with funded debt or revolvers placed with SVB. Small number of portfolio companies have bank accounts at SVB, but the "vast majority of which only hold a very limited amount of cash". No exposure to SVB at the level of Apax Funds.

----------

Future PLC - Bath, England-based magazine publisher - Says cash deposits with SVB were less than 3% of its cash on hand as at Thursday. SVB also provided GBP50 million of its GBP900 million total debt facilities. "Of this GBP50 million, approximately 48% is currently drawn," it says. Has access to "significant" liquidity, with GBP26 million cash on hand as at Friday, and GBP438 million of undrawn committed facilities, excluding SVB's undrawn hold.

----------

HgCapital Trust PLC - London-based investment firm - Says "little to no impact" on the firm from SVB collapse. Says neither Hg, nor any of its managed funds, have related loan or borrowing exposure with SVB. None of its underlying portfolio companies have outstanding borrowings with SVB. "A small number of the underlying portfolio companies have limited deposits with SVB, but no portfolio business is at risk as a result of this."

----------

LARGE SMALL-CAP AND AIM LISTINGS

----------

Team17 Group PLC - Nottingham, England-based video game development company and publisher of educational entertainment apps for children - Says Team17 USA, part of its Games Label division has legacy banking relationship with SVB, but the account is "no longer used for current trading". Says exposure to SVB is less than 1% of cash reserves at present, and "as such is immaterial to the group's liquidity position".

----------

Learning Technologies Group PLC - London-based learning and talent solutions - Says exposure to SVB and SVB UK does not have "material effect" on financial position. As at Friday, had total cash and cash equivalents of GBP110.7 million, of which around GBP11.7 million was on deposit with SVB and SVB UK. Around GBP9.4 million was with SVB, with around GBP2.3 million with SVB UK. Requested withdrawal of deposits, and has received GBP300,000 to date. "The company will continue to pursue any unreturned deposits, including if necessary through the relevant receivership process," LTG says. SVB was also part of its banking syndicate, which comprises HSBC, Bank of Ireland, and Fifth Third Bank. The facilities comprise a drawn USD255.4 million loan - with SVB providing USD53.7 million, and an undrawn revolving credit facility of USD50 million - with SVB's share being USD10.5 million. "SVB's portion of the term loan will continue to be outstanding until it is due to be repaid or SVB is replaced." Says it's unlikely SVB will fund any future drawings on RCF, but the remaining USD39.5 million will be available as normal. SVB was also facility agent for the lending syndicate, and the firm will find a replacement.

----------

THG PLC - Manchester Airport-headquartered e-commerce retail company - Confirms no exposure to SVB in relation to cash or debt facilities.

----------

RWS Holdings PLC - Buckinghamshire, England-based technology-enabled language services provider - Says exposure to SBV "limited", with SVB UK being part of its eight-bank syndicated providing USD220 million revolving credit facility, having committed around 10% of the facility. Around USD26 million is currently drawn down, of which SVB's share is USD2.7 million. Has "small" cash position held within SVB in the US, which it believes with be fully protected under the Federal Deposit Insurance Corporation scheme. SVB UK holds "a portion" of its forward currency contracts, and RWS is working to minimise its "limited" exposure to these contracts. Reiterates outlook from annual general meeting statement, expecting to delivery annual adjusted pretax profit in line with market expectations.

----------

Oxford BioMedica PLC - Oxfordshire, England-based gene and cell therapy group - Says its US facility maintains a checking and deposit account with SVB. Has no accounts with SVB UK. "Oxford Biomedica confirms it has no balance sheet risk exposure to the SVB receivership issue."

----------

Alpha Group International PLC - London-based provider of financial solutions - Says operations and client held funds unaffected by SVB situations. Reaffirms that all client funds are in segregated safeguarding accounts with tier 1 counterparties, comprised of Barclays Bank, Citibank, Goldman Sachs, and Lloyds Bank. "In addition, unlike a bank, Alpha does not use client cash to issue loans, and therefore 100% of client held funds remain in cash at all times," it explains. Says it will monitor potential knock-on effects from SVB on its clients.

----------

BioPharma Credit PLC - Winchester, England-based life sciences debt investment trust - The firm's investment adviser, Pharmakon Advisors, says firm does not hold deposits or other investments in SVB. Has consulted the firm's borrowers, and they report "no significant exposure" to SVB.

----------

OTHER

----------

Dianomi PLC - London-based digital advertising platform - Says on Thursday's close of business, it had total cash balances of around GBP9.6 million, mostly held with JPMorgan and Westpac, but around GBP3.8 million was held with SVB and SVB UK "across a variety of different currency accounts". They held GBP900,000 and GBP2.9 million respectively. Noting developments in the UK and US, now expects these deposits to be fully protected.

----------

Trustpilot Group PLC - Copenhagen-based online consumer reviews platform - Says SVB UK was principal banking partner. Its immediately accessible cash is USD24 million, made up of USD19 million cash on deposit with another bank, USD4.5 million guaranteed by the US Federal Reserve after Sunday's announcement, and amounts due to be returned under guaranteed deposit insurance schemes in UK. "The board is confident in Trustpilot's' liquidity position and resilience. Meanwhile, we have put in place measures to proactively manage our cash position during this period of uncertainty, and wider unpredictability in the current macroeconomic environment," Trustpilot says.

----------

Polarean Imaging PLC - London-based medical imaging technology company - Says at the end of February it had USD13.9 million in cash, with USD12.4 million held at SVB. USD9.8 million of the amount held by SVB is held in money market mutual fund accounts operated by other financial institutions. Also holds USD1.0 million in SVB checking account, and GBP1.2 million in SVB sterling checking account. Notes FDIC guarantees USD250,000 of deposits in US. Believes USD9.8m MMFA shares are not considered deposits of SVB, and therefore are not part of the receivership estate. "However, Polarean may not have immediate access to these funds until the FDIC establishes procedures for access," the firm says. Says USD1.5 million held by Wells Fargo will fund its working capital needs until the end of April this year.

----------

Diaceutics PLC - Belfast-based testing laboratories company - Says as at Thursday, it holds GBP19.8 million in cash and cash equivalents with SVB UK. Is now confident the funds will be fully recovered, following HSBC acquisition. Earlier, the firm had ordered the suspension of its shares on AIM, due to uncertainty about its ability to service working capital requirements. It now removes suspension. Continues trying to get access to the GBP2.2 million held on deposit with SVB in the US. Following the announcement from the Federal Reserve about restoring access to deposits, it expects to be able to access the funds in the "near term".

----------

Naked Wines PLC - Norwich-based online wine seller - Says holds cash in variety of SVB accounts in US and UK. SVB is also administrative agent and issuing lender for its USD60 million asset-backed credit facility. On Friday, had gross cash on hand of GBP32 million, GBP14 million of which was held in cash sweep account with SVB acting as custodian for third party money market funds. Believes it is entitled to return of these funds in full, after completing any procedures required by FDIC. Is uncertain of the time frame in which it will gain full access to these funds. Says day-to-day operations unaffected, and doesn't expect to incur any loss as a result. Says GBP17 million available in immediately accessible cash.

----------

Access Intelligence PLC - London-based software-as-a-service products provider - Says SVB it has deposits with less than GBP400,000 held across a number of SVB accounts in the UK and US. It expects most of the funds, if not all, to be protected by the UK Financial Services Compensation Scheme and the US FDIC. "However the exact timing of when these funds might be available to the company still remains uncertain," firm says. Notes SVB is not a banking partner of the company in the Asia-Pacific region.

----------

Glantus Holdings PLC - Dublin-based data platform for accounts payable and shared services - Says it SVB is used for US operations. "Proactively managing" situation, and does not expected significant operational difficulties. Says maximum exposure will "only slightly" exceed the USD250,000 amount insured by FDIC. "Consequently, the board is confident that the current situation regarding SVB will not have a material impact on Glantus."

----------

Medica Group PLC - Hastings, England-based company which provides services such as X-ray and MRI scan analysis to hospitals - Says SVB UK is part of three-bank lending consortium, alongside NatWest and Lloyds. Says around GBP10 million of the GBP30 million revolving credit facility was being used at the end of December. "The RCF facility is not required for day-to-day activity, is not forecast to be further drawn and Medica intends to pay this facility down out of trading cashflows within the next 12-18 months," firm says. Has no cash on deposit nor conducts any day-to-day commercial banking with any SVB entity.

----------

eEnergy Group PLC - London-based energy efficiency-as-a-service provider - Says it has no material operating cash exposure to SVB, but maintains a number of bank accounts with SVB UK, "primarily used in relation to collections from clients on behalf of project funders". Its primary relationship with SVB concerns currency hedging, and a fully drawn GBP5 million revolving credit facility. "The board does not expect any material impact to its business, adjusted earnings or cash position."

----------

Venture Life Group PLC - Berkshire, England-based self-care product manufacturer and distributor - Says SVB participates in its GBP30 million revolving credit facility, which is primarily co-ordinated and managed by firm's main relationship bank, Santander UK. SVB provides 50% of the funds drawn under the facility. The RCF has an option for Santander to take of SVB's portion, or for another lender to participate in the RCF. "The group has commenced discussions with Santander in relation to Santander doing this, and those initial discussions have been positive," VLG says. Santander and firm will accelerate plans to refinance the RCF, given that it expires next June. Says firm and subsidiaries have no deposits with SVB in UK or US, meaning no funds at risk.

----------

Checkit PLC - Cambridge-based workflow management software provider - Says exposure to SVB less than GBP100,000. Says balance sheet strong, with net cash of GBP15.6 million at January 31.

----------

PCI-PAL PLC - Global cloud provider of secure payment solutions for business communications - As of Thursday, had GBP3.2 million of cash in accounts with SVB, split between the US and UK. Notes US and UK developments ensuring safety of its deposits. Says trading in the second so far has been in line with the board's expectations.

----------

Yourgene Health PLC - Manchester-based molecular diagnostics - Says it has GBP3 million in outstanding borrowings under a loan agreement with SVB UK. Holds around GBP20,000 on deposit with SVB UK in accounts which are only used to pay loan instalments or associated interest. Says SVB US exposure is for day-to-day trading purposes for small US commercial team, and "handful" of company credit cards. Says the "modest" level of funds held in US SVB account were transferred to other banks last week. Believes remaining SVB deposits are protected by relevant insurance schemes in UK and US.

----------

musicMagpie PLC - Stockport, England-based used-technology reseller - Says it had a loan arrangement with SVB, but this ended when it entered the three-year GBP30 million revolving credit facility with HSBC and NatWest last July. Its US trading brand, decluttr, uses SVB for day-to-day activities. Says SVB closure in US is unlikely to impact business because decluttr can use alternative banking relationships. "The group had already been in discussions to move its US transactional banking relationship away from SVB," the firm says.

----------

Windward Ltd - Liverpool, England-based maritime predictive intelligence company - Says exposure "minimal", and expects funds to be protected by US and UK schemes. Says exposure amount is less than 0.5% of its cash position, which was USD22.2 million at December 31.

----------

Eagle Eye Solutions Group PLC - London-based marketing solutions provider - Says it has a GBP5.0 million loan facility with SVB UK, which is draw down by GBP2.0 million. On Friday, had total cash of around GBP7.8 million. Notes some funds deposited with SVB in US, but expects these to be protected and available from today. Has no cash deposits with SVB UK.

----------

GetBusy PLC - Cambridge, England-based document management and productivity software provider - Says its previous loan facility with SVB was cancelled last month, and replaced with a GBP2 million facility with DJZ Investments Pty Ltd. "Following this executed change, the group has no exposure to SVB for any loan facilities." Says no exposure to uninsured deposits with SVB, given the announcements from the Treasure, Federal Reserve and FDIC on Sunday.

----------

The following firms cited no banking relationship with/no exposure to SVB:

Argentex Group PLC

Avacta Group PLC

Cornerstone FS PLC

CyanConnode Holdings PLC

Equals Group PLC

Evgen Pharma PLC

Fiinu PLC

GENinCode PLC

Instem PLC

LungLife AI Inc

Mercia Asset Management PLC

Renalytix PLC

Roquefort Therapeutics PLC

Scancell Holdings PLC

Science Group PLC

Seeing Machines Ltd

Spectral MD Holdings Ltd

Tern PLC

Verici Dx PLC

----------

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
1 May 2024 11:53

IN BRIEF: Avacta picks Christina Coughlin to replace long-serving CEO

Avacta Group PLC - Wetherby, West Yorkshire-based life sciences company developing cancer treatments and diagnostics - Promotes Christina Coughlin to chief executive officer from head of Research & Development. Coughlin has been an Avacta board member since March 2022 and head of R&D since this past February. She replaces Alastair Smith, who steps down on Tuesday after 19 years as CEO. Coughlin was CEO of Cytolmmune Therapeutics, which develops cell therapy solutions from a facility in Puerto Rico. She also has worked at Pfizer Inc and Novartis AG.

Read more
30 Apr 2024 16:30

EARNINGS: Avacta sales jump; Poolbeg loss narrows; Digital 9 NAV down

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
23 Apr 2024 14:26

UK earnings, trading statements calendar - next 7 days

Wednesday 24 April 
1Spatial PLCFull Year Results
abrdn PLCTrading Statement
Ecora Resources PLCTrading Statement
Fresnillo PLCTrading Statement
Lloyds Banking Group PLCQ1 Results
Nichols PLCTrading Statement
PensionBee Group PLCFirst Quarter Results
PZ Cussons PLCTrading Statement
Quilter PLCQ1 Results
Reckitt Benckiser Group PLCTrading Statement
Sanderson Design Group PLCFull Year Results
Serica Energy PLCFull Year Results
Star Energy Group PLCFull Year Results
Tortilla Mexican Grill PLCFull Year Results
Tracsis PLCHalf Year Results
Warpaint London PLCFull Year Results
Thursday 25 April 
Aquila European Renewables PLCFull Year Results
Argo Blockchain PLCFull Year Results
AstraZeneca PLCQ1 Results
Barclays PLCQ1 Results
Checkit PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Destiny Pharma PLCFull Year Results
Dillistone Group PLCFull Year Results
Focusrite PLCHalf Year Results
Gem Diamonds LtdTrading Statement
Hikma Pharmaceuticals PLCTrading Statement
Hummingbird Resources PLCTrading Statement
Ibstock PLCTrading Statement
Inchcape PLCTrading Statement
J Sainsbury PLCFull Year Results
London Stock Exchange Group PLCQ1 Results
Persimmon PLCTrading Statement
Pinewood Technologies Group PLCFull Year Results
PPHE Hotel Group LtdTrading Statement
PureTech Health PLCFull Year Results
Relx PLCTrading Statement
Renewi PLCTrading Statement
Schroders PLCQ1 Results
Skillcast Group PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
Unilever PLCQ1 Results
WAG Payment Solutions PLCTrading Statement
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Zinc Media Group PLCFull Year Results
Friday 26 April 
Facilities by ADF PLCFull Year Results
Kingspan Group PLCTrading Statement
NatWest Group PLC Q1 Results
Pearson PLCTrading Statement
Record PLCTrading Statement
Smurfit Kappa Group PLCTrading Statement
Taylor Maritime Investments LtdTrading Statement
Monday 29 April 
Beazley PLCTrading Statement
Biome Technologies PLCFull Year Results
Christie Group PLCFull Year Results
Gresham Technologies PLCFull Year Results
Jadestone Energy PLCFull Year Results
Oxford BioMedica PLCFull Year Results
SpaceandPeople PLCFull Year Results
Tuesday 30 April 
Avacta Group PLCFull Year Results
Card Factory PLCFull Year Results
Capital & Regional PLCFull Year Results
Coca-Cola HBC AGTrading Statement
Elementis PLCTrading Statement
essensys PLCHalf Year Results
Fadel Partners IncFull Year Results
Glencore PLCTrading Statement
Hargreaves Lansdown PLC Trading Statement
Howden Joinery PLCTrading Statement
HSBC Holdings PLCQ1 Results
Kelso Group PLCFull Year Results
Northcoders Group PLCFull Year Results
Phoenix Spree Deutschland LtdFull Year Results
RBG Holdings PLCFull Year Results
Rotork PLCTrading Statement
Safestore Holdings PLCHalf Year Results
Shield Therapeutics PLCFull Year Results
St James's Place PLCTrading Statement
Whitbread PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Apr 2024 17:51

TRADING UPDATES: First Tin updates Tellerhauser estimates

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
21 Mar 2024 13:10

Avacta reaches milestone in AVA6000 dose escalation

(Sharecast News) - Avacta Group announced a significant milestone in its phase 1a dose escalation study of AVA6000, its lead 'preCISION' drug, on Thursday.

Read more
21 Mar 2024 10:37

Avacta doses third patient in drug conjugate trial for tumour tissue

(Alliance News) - Avacta Group PLC on Thursday said it dosed the third patient in the first cohort of its phase 1a dose escalation study for its lead preCision drug AVA6000.

Read more
18 Mar 2024 14:31

IN BRIEF: Avacta shareholders give AGM go-ahead to issue new shares

Avacta Group PLC - Wetherby, England-based life sciences company developing oncology drugs and diagnostics - At annual general meeting on Monday, shareholders approved the resolution to issue 23.9 million placing shares and 10.9 million Rex offer share, both at 50 pence each. This raises gross proceeds of around GBP11.9 million and GBP5.4 million respectively. Combined with proceeds from an earlier firm placing and direct subscription, the shares for which were admitted to trading on March 4, Avacta has raised total gross proceeds of GBP31.1 million.

Read more
5 Mar 2024 17:09

EARNINGS AND TRADING: Harland & Wolff wins major Falklands contract

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
29 Feb 2024 12:18

Avacta increases placing size to GBP26 million thanks to strong demand

(Alliance News) - Avacta Group PLC on Thursday said it is increasing its placing to GBP25.7 million, "in light of the strong demand."

Read more
29 Feb 2024 10:27

AIM WINNERS & LOSERS: Beacon Energy and Avacta fall on fundraise

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
29 Feb 2024 08:27

Avacta tumbles after raising £25.7m in heavily discounted placing

(Sharecast News) - Healthcare therapeutics company Avacta tumbled on Thursday after a heavily discounted placing.

Read more
28 Feb 2024 20:31

TRADING UPDATES: Avacta plans fundraise to fund clinical development

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
19 Jan 2024 11:18

Avacta appoints new head of research and development

(Sharecast News) - Oncology drugs and diagnostics developer Avacta announced the appointment of Dr Christina Coughlin as its new head of research and development for the therapeutics division on Friday.

Read more
19 Jan 2024 09:11

IN BRIEF: Avacta says new head of R&D Coughlin brings "deep expertise"

Avacta Group PLC - Wetherby, England-based life sciences company developing oncology drugs and diagnostics - Appoints Christina Coughlin as head of research and development. Coughlin, who will take up the position on February 1, has served as a non-executive director of Avacta since March 2022 and was appointed consultant in interim in September 2023. She previously served as chief executive officer of Cytoimmune Therapeutics LLC, a clinical stage biotechnology company focused on novel cancer immunotherapy products. In the new role, Coughlin will oversee clinical and pre-clinical research and development activities for the company's therapeutics division, while retaining her position on as an executive director of Avacta. The company says that Coughlin has been "pivotal" in the development strategy for its AVA6000 tumour-targeted therapy.

Read more
19 Dec 2023 10:24

Avacta appoints new chief business officer

(Sharecast News) - Oncology drugs and diagnostics specialist Avacta Group announced the appointment of Dr Simon Bennett as the chief business officer of its therapeutics division on Tuesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.